Review
Published on 06 Sep 2022
Proteostasis unbalance in prion diseases: Mechanisms of neurodegeneration and therapeutic targets
in Neurodegeneration
Frontiers in Neuroscience
doi 10.3389/fnins.2022.966019
- 5,141 views
- 10 citations
Type at least 3 characters
2,087 articles
Articles
Review
Published on 01 Sep 2022
The neuroprotective effects of glucagon-like peptide 1 in Alzheimer’s and Parkinson’s disease: An in-depth review
in Neurodegeneration
Frontiers in Neuroscience
doi 10.3389/fnins.2022.970925
- 21,379 views
- 77 citations
Original Research
Published on 01 Sep 2022
Neurofilament light as a biomarker for motor decline in Parkinson’s disease
in Neurodegeneration
Frontiers in Neuroscience
doi 10.3389/fnins.2022.959261
- 4,675 views
- 19 citations
Original Research
Published on 01 Sep 2022
Quantitative behavioral evaluation of a non-human primate stroke model using a new monitoring system
in Neurodegeneration
Frontiers in Neuroscience
doi 10.3389/fnins.2022.964928
- 3,094 views
- 1 citation
Original Research
Published on 31 Aug 2022
Biomolecules resveratrol + coenzyme Q10 recover the cell state of human mesenchymal stem cells after 1-methyl-4-phenylpyridinium-induced damage and improve proliferation and neural differentiation
in Neurodegeneration
Frontiers in Neuroscience
doi 10.3389/fnins.2022.929590
- 4,940 views
- 2 citations
Original Research
Published on 30 Aug 2022
Complement C3a receptor inactivation attenuates retinal degeneration induced by oxidative damage
in Neurodegeneration
Frontiers in Neuroscience
doi 10.3389/fnins.2022.951491
- 3,509 views
- 5 citations
Systematic Review
Published on 25 Aug 2022
Metformin use is associated with a reduced risk of cognitive impairment in adults with diabetes mellitus: A systematic review and meta-analysis
in Neurodegeneration
Frontiers in Neuroscience
doi 10.3389/fnins.2022.984559
- 8,272 views
- 15 citations
Original Research
Published on 25 Aug 2022
Small molecule modulation of the large-conductance calcium-activated potassium channel suppresses salicylate-induced tinnitus in mice
in Neurodegeneration
Frontiers in Neuroscience
doi 10.3389/fnins.2022.763855
- 3,398 views
- 5 citations
Review
Published on 24 Aug 2022
Hunting for the cause: Evidence for prion-like mechanisms in Huntington’s disease
in Neurodegeneration
Frontiers in Neuroscience
doi 10.3389/fnins.2022.946822
- 5,412 views
- 9 citations
Editorial
Published on 23 Aug 2022
Editorial: Neurodegeneration and Neuroprotection in Retinal Disease, Volume II
in Neurodegeneration
Frontiers in Neuroscience
doi 10.3389/fnins.2022.1009228
- 1,116 views
Original Research
Published on 18 Aug 2022
Quantitative susceptibility mapping of basal ganglia iron is associated with cognitive and motor functions that distinguish spinocerebellar ataxia type 6 and type 3
in Neurodegeneration
Frontiers in Neuroscience
doi 10.3389/fnins.2022.919765
- 2,817 views
- 3 citations
Review
Published on 18 Aug 2022
Cerebral edema after ischemic stroke: Pathophysiology and underlying mechanisms
in Neurodegeneration
Frontiers in Neuroscience
doi 10.3389/fnins.2022.988283
- 27,818 views
- 44 citations
Methods
Published on 17 Aug 2022
Protocol for randomized controlled trial to evaluate the safety and feasibility of a novel helmet to deliver transcranial light emitting diodes photobiomodulation therapy to patients with Parkinson’s disease
in Neurodegeneration
Frontiers in Neuroscience
doi 10.3389/fnins.2022.945796
- 6,261 views
- 14 citations
Original Research
Published on 16 Aug 2022
Alterations of brain activity in multiple system atrophy patients with freezing of gait: A resting-state fMRI study
in Neurodegeneration
Frontiers in Neuroscience
doi 10.3389/fnins.2022.954332
- 1,945 views
- 2 citations
Opinion
Published on 12 Aug 2022
Microglia activation linking amyloid-β drive tau spatial propagation in Alzheimer's disease
in Neurodegeneration
Frontiers in Neuroscience
doi 10.3389/fnins.2022.951128
- 3,771 views
- 9 citations
Original Research
Published on 11 Aug 2022
Serum metabolomic characterization of PLA2G6-associated dystonia–parkinsonism: A case-control biomarker study
in Neurodegeneration
Frontiers in Neuroscience
doi 10.3389/fnins.2022.879548
- 3,383 views
- 3 citations